Private Equity Firm Acquires Heritage Imaging

Why It Matters

The purchase gives Align a strategic foothold in rural healthcare imaging, speeding consolidation and expanding access for patients in underserved areas. It underscores growing private‑equity interest in mobile health solutions that address geographic gaps in care.

Key Takeaways

• Align Capital Partners adds mobile imaging specialist to its healthcare portfolio
• Heritage Imaging serves 14 states, targeting rural hospitals and clinics
• CEO Steve Coppess remains to lead post‑acquisition growth
• Plans include further acquisitions and expanding into new imaging modalities

Pulse Analysis

Mobile diagnostic imaging has emerged as a critical bridge for patients in remote regions, where traditional hospital infrastructure is limited. By deploying fully staffed mobile units and leasing equipment, providers can deliver PET‑CT, MRI, ultrasound and other high‑cost modalities directly to community clinics, reducing travel times and improving outcomes. Investors are increasingly recognizing this model’s scalability and resilience, especially as telehealth and decentralized care gain traction across the United States.

Heritage Imaging, founded in 1989, has built a reputation for reliable, on‑site imaging services across 14 states in the Midwest and Pacific Northwest. Its portfolio includes critical‑access hospitals, community health centers and outpatient facilities, all of which benefit from reduced capital expenditures and faster diagnostic turnaround. Since 2024, Heritage has completed three add‑on acquisitions, signaling a proactive growth strategy that aligns with the broader trend of consolidating niche healthcare services under larger platforms.

The Align Capital Partners acquisition positions the firm to capitalize on this momentum. With private‑equity backing, Heritage can accelerate its expansion into adjacent markets and introduce new modalities such as advanced cardiac imaging and nuclear medicine. This infusion of capital is likely to spur further M&A activity, prompting other investors to explore similar opportunities in the mobile health space. Ultimately, the deal promises to enhance imaging accessibility, lower costs for rural providers, and reinforce the strategic value of decentralized diagnostic services in the evolving U.S. healthcare landscape.